Citi analyst Michael Ward raised the firm’s price target on Fidelis Insurance to $21 from $17 and keeps a Buy rating on the shares post the Q4 report. The analyst believes implementation of a regular 10c dividend plus $50M buyback authorization bolster the company’s shareholder commitment. Transparency around Bespoke and pipeline updates will improve investor comfort and mitigate “undue reactions to top-line volatility,” the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on FIHL: